Infectious Diseases and Therapy

Papers
(The H4-Index of Infectious Diseases and Therapy is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Sixty years of Amphotericin B: An Overview of the Main Antifungal Agent Used to Treat Invasive Fungal Infections156
Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa112
Continuous Evolution: Perspective on the Epidemiology of Carbapenemase Resistance Among Enterobacterales and Other Gram-Negative Bacteria109
Climate Change and Cascading Risks from Infectious Disease91
Etiology of Severe Community-Acquired Pneumonia in Adults Based on Metagenomic Next-Generation Sequencing: A Prospective Multicenter Study87
The Future of Respiratory Syncytial Virus Disease Prevention and Treatment77
Preliminary Evaluation of QuantiFERON SARS-CoV-2 and QIAreach Anti-SARS-CoV-2 Total Test in Recently Vaccinated Individuals72
Efficacy of Bamlanivimab/Etesevimab and Casirivimab/Imdevimab in Preventing Progression to Severe COVID-19 and Role of Variants of Concern69
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors69
Metagenomic Next-Generation Sequencing for the Diagnosis of Pneumocystis jirovecii Pneumonia in Non-HIV-Infected Patients: A Retrospective Study64
Current Stage in the Development of Klebsiella pneumoniae Vaccines61
Ibuprofen and NSAID Use in COVID-19 Infected Patients Is Not Associated with Worse Outcomes: A Prospective Cohort Study59
Carbapenem-resistant Acinetobacter baumannii: Colonization, Infection and Current Treatment Options59
Ceftazidime-Avibactam for the Treatment of Serious Gram-Negative Infections with Limited Treatment Options: A Systematic Literature Review58
Interpretable Machine Learning for Early Prediction of Prognosis in Sepsis: A Discovery and Validation Study57
Current State of Respiratory Syncytial Virus Disease and Management57
Refining “Long-COVID” by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 Infection56
Efficacy and Safety of Favipiravir in Moderate COVID-19 Pneumonia Patients without Oxygen Therapy: A Randomized, Phase III Clinical Trial52
Clostridium difficile: Diagnosis and the Consequence of Over Diagnosis50
Legionnaires’ Disease: Update on Diagnosis and Treatment50
In Search of the SARS-CoV-2 Protection Correlate: Head-to-Head Comparison of Two Quantitative S1 Assays in Pre-characterized Oligo-/Asymptomatic Patients50
A Rapid, High-Sensitivity SARS-CoV-2 Nucleocapsid Immunoassay to Aid Diagnosis of Acute COVID-19 at the Point of Care: A Clinical Performance Study49
Influence of Baseline Physical Activity as a Modifying Factor on COVID-19 Mortality: A Single-Center, Retrospective Study49
Coccidioidomycosis: A Contemporary Review48
The Global Trends and Regional Differences in Incidence of Dengue Infection from 1990 to 2019: An Analysis from the Global Burden of Disease Study 201947
Fatal Infections Among Cancer Patients: A Population-Based Study in the United States47
Potential Adverse Effects of Dexamethasone Therapy on COVID-19 Patients: Review and Recommendations42
Exploring the Clinical Utility of Metagenomic Next-Generation Sequencing in the Diagnosis of Pulmonary Infection39
Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study39
Computational and Experimental Studies Reveal That Thymoquinone Blocks the Entry of Coronaviruses Into In Vitro Cells36
Durability of Vaccine-Induced and Natural Immunity Against COVID-19: A Narrative Review36
The Effect of Probiotics Supplementation on Gut Microbiota After Helicobacter pylori Eradication: A Multicenter Randomized Controlled Trial35
Meta-Regression of Herpes Zoster Incidence Worldwide35
Adjusting for Case Under-Ascertainment in Estimating RSV Hospitalisation Burden of Older Adults in High-Income Countries: a Systematic Review and Modelling Study35
0.18243193626404